WO2012025229A8 - Composition and method of manufacture - Google Patents
Composition and method of manufacture Download PDFInfo
- Publication number
- WO2012025229A8 WO2012025229A8 PCT/EP2011/004254 EP2011004254W WO2012025229A8 WO 2012025229 A8 WO2012025229 A8 WO 2012025229A8 EP 2011004254 W EP2011004254 W EP 2011004254W WO 2012025229 A8 WO2012025229 A8 WO 2012025229A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- age
- reducing
- combination
- progression
- vitamin
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 206010064930 age-related macular degeneration Diseases 0.000 abstract 3
- 208000002780 macular degeneration Diseases 0.000 abstract 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 abstract 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 abstract 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 abstract 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 abstract 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 235000021323 fish oil Nutrition 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 235000012680 lutein Nutrition 0.000 abstract 1
- 229960005375 lutein Drugs 0.000 abstract 1
- 239000001656 lutein Substances 0.000 abstract 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 abstract 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 235000021283 resveratrol Nutrition 0.000 abstract 1
- 229940016667 resveratrol Drugs 0.000 abstract 1
- 235000013974 saffron Nutrition 0.000 abstract 1
- 239000004248 saffron Substances 0.000 abstract 1
- 239000011885 synergistic combination Substances 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 abstract 1
- 235000010930 zeaxanthin Nutrition 0.000 abstract 1
- 239000001775 zeaxanthin Substances 0.000 abstract 1
- 229940043269 zeaxanthin Drugs 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2809071A CA2809071C (en) | 2010-08-27 | 2011-08-25 | Composition and method of manufacture |
AU2011295398A AU2011295398B2 (en) | 2010-08-27 | 2011-08-25 | Composition and method of manufacture |
US13/819,173 US9486464B2 (en) | 2010-08-27 | 2011-08-25 | Composition and method of manufacture |
GB1305581.9A GB2498660B (en) | 2010-08-27 | 2011-08-25 | A composition comprising resveratrol and saffron |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1014340.2A GB201014340D0 (en) | 2010-08-27 | 2010-08-27 | Nutritional supplement formulation comprising saffron and resveratrol |
GBGB1014340.2 | 2010-08-27 | ||
GBGB1100925.5 | 2011-01-19 | ||
GB1100925.5A GB2483121A (en) | 2010-08-27 | 2011-01-19 | Composition comprising resveratrol and saffron |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012025229A1 WO2012025229A1 (en) | 2012-03-01 |
WO2012025229A8 true WO2012025229A8 (en) | 2012-10-11 |
Family
ID=45722920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2011/004254 WO2012025229A1 (en) | 2010-08-27 | 2011-08-25 | Composition and method of manufacture |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012025229A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201014340D0 (en) | 2010-08-27 | 2010-10-13 | Piraee Mahmood | Nutritional supplement formulation comprising saffron and resveratrol |
FR2995185A1 (en) * | 2012-09-13 | 2014-03-14 | Mundema | Edible composition, useful as a soothing agent for treating obesity, comprises a flower extract of Crocus sativus having specified particle size and specified safranal content |
CN105283190A (en) * | 2013-06-13 | 2016-01-27 | 飞鱼有限公司 | A marine oil formulation comprising reservatrol or derivatives thereof for use in treating, delaying and/or preventing alzheimer's desease |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63109788A (en) | 1986-06-06 | 1988-05-14 | Ajinomoto Co Inc | Production of safranal, crocin or analog thereof |
US5654003A (en) | 1992-03-05 | 1997-08-05 | Fuisz Technologies Ltd. | Process and apparatus for making tablets and tablets made therefrom |
CN1059444C (en) | 1994-11-29 | 2000-12-13 | 中国药科大学 | Composition for curing angicardiopathy and its production and usage |
US6573299B1 (en) * | 1999-09-20 | 2003-06-03 | Advanced Medical Instruments | Method and compositions for treatment of the aging eye |
US20090169585A1 (en) | 2003-10-23 | 2009-07-02 | Resveratrol Partners, Llc | Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity |
ITRM20050446A1 (en) * | 2005-08-19 | 2007-02-20 | Tubilux Pharma S P A | USE OF HYDROXYLATED AND GLUCOSIDATED STYLBENES FOR THE PREVENTION AND TREATMENT OF EYE PATHOLOGIES. |
CN101062339A (en) | 2007-05-23 | 2007-10-31 | 魏荣祥 | Medicine for treating diabetes |
CN101514216B (en) | 2008-02-22 | 2012-05-23 | 四川大学 | Method for synthesizing crocin glucoside |
CN101361892B (en) * | 2008-10-09 | 2011-04-06 | 陕西东泰制药有限公司 | Traditional Chinese medicine formulation for treating cataract and preparation method thereof |
JP2010195779A (en) | 2009-02-18 | 2010-09-09 | Omnica Gmbh | Hydrolysate of crocin |
CN101597554A (en) | 2009-06-16 | 2009-12-09 | 赵宇 | The thick wine of one kind of plant |
-
2011
- 2011-08-25 WO PCT/EP2011/004254 patent/WO2012025229A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2012025229A1 (en) | 2012-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2498660A (en) | Composition and method of manufacture | |
TN2009000241A1 (en) | Nutritional supplement composition for treatment of ocular diseases | |
WO2007076416A3 (en) | Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision | |
EP3085365A3 (en) | Synergistic combinations of carotenoids and polyphenols | |
IN2014MU01128A (en) | ||
WO2012013861A3 (en) | Use of blood group status iii | |
WO2007114945A3 (en) | Compositions and methods for enhancing the antioxidant status of animals | |
MX2014004722A (en) | Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease. | |
WO2009037562A3 (en) | Nutritional supplement formulations and fortified foods comprising such supplements | |
JP2014524914A5 (en) | ||
MX2012000743A (en) | Oil-based coating for baked food products. | |
MX2018002543A (en) | Compositions comprising urolithin compounds. | |
EP3592158A4 (en) | Dietary supplements, food ingredients and foods comprising high-protein algal biomass | |
WO2012025229A8 (en) | Composition and method of manufacture | |
EP2522226A3 (en) | Composition for the preserving of caviare from fish grown in aquaculture | |
ATE397389T1 (en) | FORMULATION FOR ORAL ADMINISTRATION WITH HEALTH-PROMOTING EFFECTS ON THE CARDIOVASCULAR SYSTEM | |
WO2006117826A3 (en) | Composition comprising olive oil enriched and supplemented with lutein | |
PH12017500357A1 (en) | Lactic acid bacteria-containing composition | |
NZ761512A (en) | Prevention and/or treatment of neurodegenerative disease | |
WO2013007447A3 (en) | Edible composition | |
EP3826630A4 (en) | Cannabinoids compositions with polyunsaturated fatty acid monoglycerides, methods and uses thereof | |
MY187748A (en) | Compositions and method for maintaining/improving cognitive function | |
MY188896A (en) | Methods and compositions for reducing digestive/absorptive rates and ratio of food/drinks or reducing a digestive solution | |
WO2011076557A8 (en) | Use of canthaxanthin and/or 25-oh d3 for improved reproductivity and performance of roosters | |
MY173530A (en) | Gluten-free food product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11754999 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase in: |
Ref document number: 2809071 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13819173 Country of ref document: US |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
ENP | Entry into the national phase in: |
Ref document number: 1305581 Country of ref document: GB Kind code of ref document: A Free format text: PCT FILING DATE = 20110825 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1305581.9 Country of ref document: GB |
|
ENP | Entry into the national phase in: |
Ref document number: 2011295398 Country of ref document: AU Date of ref document: 20110825 Kind code of ref document: A |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11754999 Country of ref document: EP Kind code of ref document: A1 |